DelveInsight's 'Severe Asthma Pipeline Insight 2024' report provides comprehensive global coverage of pipeline severe asthma ...

Over 40 companies are working on more than 50 therapies for severe asthma. The severe asthma market is growing due to a ...

AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...

Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics ...

for asthma treatment were associated with reduced risks of severe exacerbations compared with bronchodilator-only relievers, a meta-analysis showed. Compared with bronchodilator-only relievers ...

This study highlights the benefits of anti-inflammatory inhalers in asthma management, showing reduced complications and ...

One of the reasons that Black children have higher rates of asthma is their comorbid conditions. For instance, obesity is ...

Patients with asthma who switched biologics multiple times were younger, more likely to identify as Black, and had more ...

The study that Community Health Center patients, like Cridele, have been participating in seeks to alleviate the strain on rural patients by testing their lung performance at home, with a mobile ...

Tessa Romero, an analyst from J.P. Morgan, has initiated a new Buy rating on Upstream Bio, Inc. (UPB). Tessa Romero’s rating is based on ...

Upstream Bio, Inc. (UPB) has received a new Buy rating, initiated by TD Cowen analyst, Yaron Werber. Yaron Werber has given his Buy rating due ...

Many studies suggest that an earlier age at menopause is more detrimental to a woman's health, leading to an increased risk ...